Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a point-of-care health testing technology innovator, has rolled out its trademarked HealthTab(TM) platform in select Ontario and British Columbia Shoppers Drug Mart network pharmacies. The company continues to add lab-accurate test functionality to its kiosks, most recently announcing a solution for monitoring kidney function. Already, Avricore has agreements with Abbott Laboratories currently in the pilot stage that allow for the testing of markers related to conditions such as diabetes, heart disease and viruses such as SARS-CoV-2, RSV, influenza A and B, and strep, empowering patients who want to take a greater role in managing their conditions. “Avricore’s purpose is to likewise empower community pharmacies, particularly those in Canada whose revenues were impacted by the Pan-Canadian Select Molecule Price Initiative for Generic Drugs in 2018 that reduced retail margins in reimbursements,” reads a recent article. “We’ve demonstrated a unique resilience by remaining focused on our goal of creating the world’s largest rapid testing network in pharmacy,” Avricore CEO Hector Bremner stated earlier this year. “We are well on our way to making actionable health information more accessible for everyone and dramatically expanding our network in the coming months.”
To view the full article, visit https://ibn.fm/RSYFh
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM), (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, visit www.AvricoreHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
